Arteris (AIP) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Achieved record annual contract value plus royalties of $60.5 million in Q3 2024, up 6% year-over-year, driven by strong demand for AI-driven enterprise computing, automotive SoC solutions, and expanded adoption among top-tier customers.
Positive free cash flow of $1.1 million for the third consecutive quarter, reflecting effective cost management and operational execution.
Expanded customer base and product adoption, including a top five global technology company, leading automotive and AI chip companies, and new wins in data center and microcontroller markets.
Introduced NoC tiling innovation to accelerate AI SoC design, with significant customer interest and expected revenue impact in 2025.
Strengthened leadership with new Board and executive appointments, including Joachim Kunkel and Ken Way.
Financial highlights
Q3 2024 revenue was $14.7 million, up 11% year-over-year and at the midpoint of guidance.
GAAP gross profit was $13.3 million (90% margin); non-GAAP gross profit was $13.5 million (92% margin).
GAAP operating loss was $7.9 million, improved from $8.5 million a year ago; non-GAAP operating loss was $3.3 million, a $1.2 million year-over-year improvement.
Net loss was $7.7 million (GAAP) and $3.1 million (non-GAAP); diluted net loss per share was $0.20 (GAAP) and $0.08 (non-GAAP).
Ended Q3 with $54.5 million in cash, cash equivalents, and investments.
Outlook and guidance
Q4 2024 guidance: ACV plus royalties of $63M–$67M, revenue of $14.7M–$15.7M, non-GAAP operating loss of $5M–$4M, and non-GAAP free cash flow of -$0.9M to $1.1M.
Full year 2024 guidance: ACV plus royalties of $63M–$67M (up over 16% YoY at midpoint), revenue of $56.9M–$57.9M, non-GAAP operating loss of $17.1M–$16.1M, and non-GAAP free cash flow of $0.7M–$2.7M.
Improved guidance for revenue, operating income, and free cash flow for the full year.
Management expects continued investment in R&D and global expansion, with R&D expenses anticipated to increase as a percentage of revenue in the near term.
Cash, cash equivalents, and investments are expected to be sufficient to meet operational needs for at least the next 12 months.
Latest events from Arteris
- Record revenue and contract value growth, with strong 2026 guidance and profitability targeted.AIP
Q4 202512 Feb 2026 - 985,675 shares registered for resale post-acquisition; no proceeds to the company.AIP
Registration Filing12 Feb 2026 - FY 2025 revenue grew 22% with strong AI-driven demand and robust royalty expansion.AIP
Corporate presentation12 Feb 2026 - Targeting $100M revenue in three years, driven by AI, automotive, and microcontroller IP growth.AIP
27th Annual Needham Growth Conference3 Feb 2026 - Q2 revenue $14.6M, record ACV, positive cash flow, and raised FY 2024 guidance.AIP
Q2 20242 Feb 2026 - Accelerating royalty growth, product innovation, and strong customer retention drive expansion.AIP
28th Annual Needham Growth Conference Virtual16 Jan 2026 - Record Q4 revenue and ACV growth driven by AI and automotive demand, with improved cash flow.AIP
Q4 202423 Dec 2025 - $200M shelf registration includes $75M ATM offering via Jefferies to fund growth and acquisitions.AIP
Registration Filing16 Dec 2025 - Shareholders to elect directors and ratify auditor amid strong growth and robust governance.AIP
Proxy Filing2 Dec 2025